-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Talazoparib in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Talazoparib in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Talazoparib in Relapsed Acute Myeloid Leukemia Drug Details: Talazoparib (Talzenna,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Talazoparib in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Talazoparib in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Talazoparib in Non-Small Cell Lung Cancer Drug Details: Talazoparib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Favezelimab + Pembrolizumab) in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Favezelimab + Pembrolizumab) in Esophageal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Favezelimab + Pembrolizumab) in Esophageal Cancer Drug Details: MK-4280A is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lysergic Acid Diethylamide in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lysergic Acid Diethylamide in Major Depressive Disorder report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lysergic Acid Diethylamide in Major Depressive Disorder Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NEO-100 in Meningioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NEO-100 in Meningioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.NEO-100 in MeningiomaDrug Details:NEO-100 is under development for the treatment of glioblastoma multiforme, and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NEO-201 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NEO-201 in Endometrial Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.NEO-201 in Endometrial Cancer Drug Details:NEO-201 (h16C3) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NEO-100 in Recurrent Glioblastoma Multiforme (GBM)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. NEO-100 in Recurrent Glioblastoma Multiforme (GBM) Drug Details: NEO-100 is under development for the treatment...
-
Product Insights
NewCardiac Valve Repair Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Valve Repair Devices Pipeline Market Report Overview Cardiac valve repair devices are used in Open-Heart surgery to repair the malfunctioning of valves. Only mitral valve repair has been covered under this segment. Annuloplasty is a technique used to repair an enlarged annulus. This annuloplasty device makes the opening of the valve smaller and provides support to the valve so it can close more tightly. One unit refers to One cardiac valve repair device. The Cardiac Valve Repair Devices pipeline...
-
Sector Analysis
Europe Egaming Market – Latest Developments, Telco Value Propositions and Monetization
Europe eGaming Market Report Overview The video game industry is growing and evolving owing to technical innovation. The emergence of non-conventional distribution channels (e.g., cloud gaming) and changing consumer demands such as eSports and in-app micro-transactions have also revolutionized the industry. Furthermore, technologies such as AR/VR, cloud, and 5G are expected to drive innovation in the gaming industry and propel penetration in emerging markets. Buy the Full Report for More Insights Europe eGaming Market Download a Free Sample Report The...